1 Min Read
Dec 18 (Reuters) - Targovax ASA:
* REG-TARGOVAX ANNOUNCES THAT TG02 HAS PASSED THE INITIAL SAFETY REVIEW IN THE FIRST-IN-MAN CLINICAL TRIAL IN COLORECTAL CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.